Used in research to detect and study the expression of the DCBLD2 (also known as ESDN) protein in various tissues, particularly in vascular and cancer biology. This antibody enables immunohistochemistry, Western blotting, and flow cytometry applications to investigate the role of DCBLD2 in endothelial cell function, tumor angiogenesis, and potential involvement in diseases such as glioblastoma and other cancers. It serves as a tool for validating target engagement and assessing protein localization in preclinical studies.